Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Julien Perino"'
Autor:
Julien Perino, Nicole M. Thielens, Erika Crouch, Danièle Spehner, Jean-Marc Crance, Anne-Laure Favier
Publikováno v:
Viruses, Vol 5, Iss 3, Pp 928-953 (2013)
Vaccinia virus (VACV) was used as a surrogate of variola virus (VARV) (genus Orthopoxvirus), the causative agent of smallpox, to study Orthopoxvirus infection. VARV is principally transmitted between humans by aerosol droplets. Once inhaled, VARV fir
Externí odkaz:
https://doaj.org/article/251b4149e88343f089f8e11a9e9a5ccb
Publikováno v:
Virologie (Montrouge, France). 15(4)
Autor:
Laurent Kodjikian, Francine Behar-Cohen, Pascale Massin, Florent Aptel, Catherine Deloche, Sophie de Brouwer, Catherine Creuzot-Garcher, Julien Perino, Jean-Marc Combette, Christophe Chiquet, Jean-Paul Berrod, Bridget-Anne Kirwan
Publikováno v:
American Journal of Ophthalmology. 174:76-84
To evaluate the efficacy and safety of XG-102 (brimapitide) compared to dexamethasone eye drops in the treatment of postoperative ocular inflammation.Multicenter, randomized, parallel group, double-masked, noninferiority clinical trial.Patients who u
Autor:
Bridget-Anne Kirwan, Catherine Deloche, Julien Perino, Francine Behar-Cohen, Talal Beydoun, Jean-Marc Combette
Publikováno v:
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association For Ocular Pharmacology and Therapeutics, vol. 31, no. 2, pp. 93-9
Purpose: We aimed to investigate the safety, tolerability, and systemic diffusion of a single escalating dose of XG-102 (a 31-D-amino-acid peptide inhibiting JNK pathway activation), administered subconjunctivally in the treatment of post-surgery or
Autor:
David Crouzier, Daniel Garin, Anne-Laure Favier, Julien Perino, Jean-Claude Debouzy, Jean-Marc Crance, Danièle Spehner
Publikováno v:
Antiviral Research. 89:89-97
Vaccinia virus (VACV) was used as a surrogate of Variola virus (genus Orthopoxvirus), the causative agent of smallpox, to study orthopoxvirus infection via the respiratory airway. Lung surfactant, a physiological barrier to infection encountered by t
Autor:
Julien Perino, Catherine Deloche, Sébastien Mouz, Claire Abadie, Luis Lopez-Lazaro, Jean-Marc Combette
Publikováno v:
Pharmacology Research & Perspectives
The aim of the study is to evaluate the safety, tolerability and pharmacokinetics (PK) of the JNK inhibitor XG-102 in a randomized, double blind, placebo controlled, sequential ascending dose parallel group Phase 1 Study. Three groups of male subject
Autor:
Erika C. Crouch, Julien Perino, Danièle Spehner, Anne-Laure Favier, Nicole M. Thielens, Jean-Marc Crance
Publikováno v:
Viruses
Viruses, MDPI, 2013, 5 (3), pp.928-53
Viruses, Vol 5, Iss 3, Pp 928-953 (2013)
Viruses, 2013, 5 (3), pp.928-53
Viruses; Volume 5; Issue 3; Pages: 928-953
Viruses, MDPI, 2013, 5 (3), pp.928-53
Viruses, Vol 5, Iss 3, Pp 928-953 (2013)
Viruses, 2013, 5 (3), pp.928-53
Viruses; Volume 5; Issue 3; Pages: 928-953
International audience; Vaccinia virus (VACV) was used as a surrogate of variola virus (VARV) (genus Orthopoxvirus), the causative agent of smallpox, to study Orthopoxvirus infection. VARV is principally transmitted between humans by aerosol droplets
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5632ed0e095e3499e4bc9e3fe74f5c5a
https://hal.univ-grenoble-alpes.fr/hal-01322444
https://hal.univ-grenoble-alpes.fr/hal-01322444
Autor:
Roselyn J. Eisenberg, Chwan Hong Foo, Gary H. Cohen, Danièle Spehner, Julien Perino, Anne-Laure Favier, Jean-Marc Crance
Publikováno v:
Biology of the cell. 103(7)
Background information. Vaccinia virus (VACV) was used as a surrogate of variola virus (genus Orthopoxvirus), the causative agent of smallpox, to study orthopoxvirus infection. VACV infects cells via attachment and fusion of the viral membrane with t
Autor:
Daniel Garin, Aude Garcel, Robert Drillien, Julien Perino, Jean-Marc Crance, Anne-Laure Favier
Publikováno v:
Vaccine
Vaccine, Elsevier, 2009, 27 (5), pp.708-17. ⟨10.1016/j.vaccine.2008.11.063⟩
Vaccine, 2009, 27 (5), pp.708-17. ⟨10.1016/j.vaccine.2008.11.063⟩
Vaccine, Elsevier, 2009, 27 (5), pp.708-17. ⟨10.1016/j.vaccine.2008.11.063⟩
Vaccine, 2009, 27 (5), pp.708-17. ⟨10.1016/j.vaccine.2008.11.063⟩
International audience; As an initial step in the development of a second-generation smallpox vaccine derived from the Lister strain, to be prepared for a variola virus threat, diversity of the traditional vaccine was examined by characterizing a ser
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::679fbcfb08cde057851aafe7bca6a180
https://www.hal.inserm.fr/inserm-00357413
https://www.hal.inserm.fr/inserm-00357413
Publikováno v:
Virology Journal, Vol 7, Iss 1, p 379 (2010)
Virology Journal
Virology Journal
Background The lung would be the first organ targeted in case of the use of Variola virus (the causative agent of smallpox) as a bioweapon. Pulmonary surfactant composed of lipids (90%) and proteins (10%) is considered the major physiological barrier